Latest Breaking News On - Midodrine hydrochloride tablets - Page 1 : vimarsana.com

Alembic Pharma bags USFDA final nod for orthostatic hypotension tablets January 22, 2021 Alembic Pharmaceuticals R&D BioEquivalance Centre at Vadodara in Gujarat× Alembic Pharmaceuticals Limited has received the US drug regulator- US Food & Drug Administration (USFDA) s approval for its Abbreviated New Drug Application (ANDA) Midodrine Hydrochloride Tablets USP, 2.5 mg,5 mg, and 10 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), ProAmatine Tablets, 2.5 mg, 5 mg, and 10 mg, of Takeda Pharmaceuticals USA, Inc. (Takeda). Midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (OH). Midodrine Hydrochloride Tablets USP 2.5 mg, 5 mg, and 10 mg have an estimated market size of USD 60 million for twelve months ending September 2020, according to IQVIA.

Takeda pharmaceuticals united states incAlembic pharmaceuticalsUs food drug administrationAlembic pharmaceuticals limitedDrug administrationAbbreviated new drug applicationMidodrine hydrochloride tabletsProamatine tabletsTakeda pharmaceuticals united statesடாகேடா மருந்துகள் ஒன்றுபட்டது மாநிலங்களில் இன்க்அலெம்பிக் மருந்துகள்அலெம்பிக் மருந்துகள் வரையறுக்கப்பட்டவைடாகேடா மருந்துகள் ஒன்றுபட்டது மாநிலங்களில்